Evidence map›Paper›PMID 32800861›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Translation of genomic epidemiology of infectious pathogens: Enhancing African genomics hubs for outbreaks.

Mary Aigbiremo Oboh, Semeeh Akinwale Omoleke, Olumide Ajibola, Jarra Manneh, Abdoulie Kanteh, Abdul-Karim Sesay, Alfred Amambua-Ngwa

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.Experimental biology and medicine (Maywood, N.J.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mary Aigbiremo ObohMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK, Fajara, The Gambia. Electronic address: moboh@mrc.gm.
Semeeh Akinwale OmolekeImmunization, Vaccines and Emergencies Unit, World Health Organization, Birnin Kebbi, Kebbi State Field Office, Nigeria.
Olumide AjibolaMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK, Fajara, The Gambia; First Technical University, Ibadan, Oyo State, Nigeria.
Jarra MannehMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK, Fajara, The Gambia.
Abdoulie KantehMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK, Fajara, The Gambia.
Abdul-Karim SesayMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK, Fajara, The Gambia.
Alfred Amambua-NgwaMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK, Fajara, The Gambia.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundDeadly emerging infectious pathogens pose an unprecedented challenge to health systems and economies, especially across Africa, where health care infrastructure is weak, and poverty rates remain high. Genomic technologies are vital for enhancing the understanding and development of intervention approaches against these pathogens, including Ebola and the novel coronavirus disease 2019 (COVID-19). DISCUSSION: Africa has contributed few genomes of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) to the global pool in growing open access repositories. To bridge this gap, the Africa Centre for Disease Control and Prevention (ACDC) is coordinating continent-wide initiatives to establish genomic hubs in selected well-resourced African centres of excellence. This will allow for standardisation and efficient and rapid data generation and curation. However, the strategy to ensure capacity for high-throughput genomics at selected hubs should not overshadow the deployment of portable, field-friendly and technically less demanding genomics technologies in all affected countries. This will enhance small-scale local genomic surveillance in outbreaks, leaving validation and large-scale approaches to be taken at central genomic hubs.

conclusionThe ACDC needs to scale-up its campaign for government support across African Union countries to ensure the sustainable financing of its strategy for increased pathogen genomic intelligence and other interventions in current and inevitable future epidemics in Africa.

Indexed as

GenomicsAfricaBetacoronavirusCommunicable Diseases, EmergingCoronavirus InfectionsCOVID-19Disease OutbreaksHemorrhagic Fever, EbolaHumansPandemicsPneumonia, ViralSARS-CoV-2ACDCAfricaCOVID-19Genomic hubsGISAID

Identifiers

PMID32800861
PMCPMC7423511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.